GE HealthCare: buys out remaining 50% stake in Japan's NMP

(CercleFinance.com) - GE HealthCare announced on Monday that it had reached an agreement to acquire from Sumitomo Chemical the 50% stake in Nihon Medi-Physics that it did not already own.


The American healthcare equipment manufacturer says that the takeover of Japanese company NMP will enable the latter to develop its single-photon emission computed tomography (SPECT) and positron emission tomography (PET) retechnologies.

Its portfolio includes products such as Vizamyl, a radiopharmaceutical indicated for imaging, notably used in the diagnosis of Alzheimer's disease, and DaTScan, used to help in the differential diagnosis between Lewy and Parkinson's dementia.

Founded in 1973 and based in Tokyo, NMP has 13 production sites and last year generated sales of $183m in 2023.

GE HealthCare has held a 50% stake in NMP since the acquisition of Amersham in 2004, and has three seats on the board of directors.

The group expects to complete the transaction in early 2025.


Copyright (c) 2024 CercleFinance.com. All rights reserved.